Skip to main content
Top
Published in: BMC Nephrology 1/2023

Open Access 01-12-2023 | Malnutrition | Research

Could cooling dialysate improve inflammatory and nutritional status of hemodialysis patients?

Authors: Asmaa Elemshaty, Nagy Sayed-Ahmed, Abeer Mesbah, Mohammed Kamal Nassar

Published in: BMC Nephrology | Issue 1/2023

Login to get access

Abstract

Background

It has been shown that dialysate cooling (lowering the dialysate temperature to 0.5 °C below central body temperature) reduces the incidence of intradialytic hypotension. Other influences on hemodialysis patients, however, have not been adequately investigated. The purpose of this study was to determine the impact of individualized dialysate cooling on nutritional and inflammatory parameters in chronic hemodialysis (HD) patients.

Methods

Seventy HD patients were separated into two groups: group A: (control group) standard dialysate temperature was 37 °C, and group B: (intervention group) dialysate temperature was 0.5 °C below core body temperature. In addition to routine laboratory tests, blood pressure, anthropometric measurements, inflammatory markers, and the malnutrition inflammation score (MIS) were calculated.

Results

After six months of dialysate cooling, intradialytic hypotension episodes were much less prevalent in the intervention group (p = 0.001). Serum ferritin, transferrin saturation (TSAT), high sensitive C-reactive protein (HS-CRP), and Interleukin-6 (IL-6) reduced following dialysate cooling, whereas serum albumin rose. In the control group, IL-6 dropped but serum ferritin, TSAT, albumin, and HS-CRP rose. In both groups, hemoglobin levels dropped, and erythrocyte sedimentation rate (ESR) rose, both groups’ midarm muscle circumference and MIS worsened.

Conclusion

Cold dialysate decreased intradialytic hypotension with no significant improvement of the nutritional and inflammatory surrogates. However, more studies including larger number of patients with longer duration of follow up are required to adequately assess its effect on inflammation and nutrition in chronic hemodialysis patients.
Literature
1.
go back to reference Eckardt K-U, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, Levin A. Evolving importance of kidney disease: from subspecialty to global health burden. The Lancet. 2013;382(9887):158–69.CrossRef Eckardt K-U, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, Levin A. Evolving importance of kidney disease: from subspecialty to global health burden. The Lancet. 2013;382(9887):158–69.CrossRef
2.
go back to reference Mills KT, Xu Y, Zhang W, Bundy JD, Chen C-S, Kelly TN, Chen J, He J. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–7.CrossRefPubMedPubMedCentral Mills KT, Xu Y, Zhang W, Bundy JD, Chen C-S, Kelly TN, Chen J, He J. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–7.CrossRefPubMedPubMedCentral
3.
go back to reference Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47(1):186–92.CrossRefPubMed Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, Barre PE. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47(1):186–92.CrossRefPubMed
4.
go back to reference Stenvinkel P. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif. 2001;19(2):143–51.CrossRefPubMed Stenvinkel P. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif. 2001;19(2):143–51.CrossRefPubMed
5.
go back to reference Caimi G, Carollo C, Presti RL. Pathophysiological and clinical aspects of malnutrition in chronic renal failure. Nutr Res Rev. 2005;18(1):89–97.CrossRefPubMed Caimi G, Carollo C, Presti RL. Pathophysiological and clinical aspects of malnutrition in chronic renal failure. Nutr Res Rev. 2005;18(1):89–97.CrossRefPubMed
6.
go back to reference Enia G, Sicuso C, Alati G, Zoccali C, Pustorino D, Biondo A. Subjective global assessment of nutrition in dialysis patients. Nephrol Dialysis Transplantation. 1993;8(10):1094–8. Enia G, Sicuso C, Alati G, Zoccali C, Pustorino D, Biondo A. Subjective global assessment of nutrition in dialysis patients. Nephrol Dialysis Transplantation. 1993;8(10):1094–8.
7.
go back to reference Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, Mitch WE, Price SR, Wanner C, Wang AYM, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a Consensus Statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23(2):77–90.CrossRefPubMed Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, Mitch WE, Price SR, Wanner C, Wang AYM, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a Consensus Statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23(2):77–90.CrossRefPubMed
8.
go back to reference Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B. Serum albumin, C-Reactive protein, interleukin 6, and Fetuin A as Predictors of Malnutrition, Cardiovascular Disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006;47(1):139–48.CrossRefPubMed Honda H, Qureshi AR, Heimbürger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B. Serum albumin, C-Reactive protein, interleukin 6, and Fetuin A as Predictors of Malnutrition, Cardiovascular Disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006;47(1):139–48.CrossRefPubMed
9.
go back to reference Eldehni MT, Odudu A, McIntyre CW. Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol. 2015;26(4):957–65.CrossRefPubMed Eldehni MT, Odudu A, McIntyre CW. Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol. 2015;26(4):957–65.CrossRefPubMed
10.
go back to reference Dheenan S, Henrich WL. Preventing dialysis hypotension: a comparison of usual protective maneuvers. Kidney Int. 2001;59(3):1175–81.CrossRefPubMed Dheenan S, Henrich WL. Preventing dialysis hypotension: a comparison of usual protective maneuvers. Kidney Int. 2001;59(3):1175–81.CrossRefPubMed
11.
go back to reference van der Sande FM, Wystrychowski G, Kooman JP, Rosales L, Raimann J, Kotanko P, Carter M, Chan CT, Leunissen KML, Levin NW. Control of core temperature and blood pressure stability during hemodialysis. Clin J Am Soc Nephrol. 2009;4(1):93–8.CrossRefPubMedPubMedCentral van der Sande FM, Wystrychowski G, Kooman JP, Rosales L, Raimann J, Kotanko P, Carter M, Chan CT, Leunissen KML, Levin NW. Control of core temperature and blood pressure stability during hemodialysis. Clin J Am Soc Nephrol. 2009;4(1):93–8.CrossRefPubMedPubMedCentral
12.
13.
go back to reference Odudu A, Eldehni MT, McCann GP, McIntyre CW. Randomized Controlled Trial of Individualized Dialysate cooling for Cardiac Protection in Hemodialysis Patients. Clin J Am Soc Nephrol. 2015;10(8):1408–17.CrossRefPubMedPubMedCentral Odudu A, Eldehni MT, McCann GP, McIntyre CW. Randomized Controlled Trial of Individualized Dialysate cooling for Cardiac Protection in Hemodialysis Patients. Clin J Am Soc Nephrol. 2015;10(8):1408–17.CrossRefPubMedPubMedCentral
14.
go back to reference Garg AX, Al-Jaishi AA, Dixon SN, Sontrop JM, Anderson SJ, Bagga A, Benjamin DS, Berry WA, Blake PG, Chambers LC. Personalised cooler dialysate for patients receiving maintenance haemodialysis (MyTEMP): a pragmatic, cluster-randomised trial. The Lancet. 2022;400(10364):1693–703.CrossRef Garg AX, Al-Jaishi AA, Dixon SN, Sontrop JM, Anderson SJ, Bagga A, Benjamin DS, Berry WA, Blake PG, Chambers LC. Personalised cooler dialysate for patients receiving maintenance haemodialysis (MyTEMP): a pragmatic, cluster-randomised trial. The Lancet. 2022;400(10364):1693–703.CrossRef
15.
go back to reference Gul A, Miskulin D, Harford A, Zager P. Intradialytic hypotension. Curr Opin Nephrol Hypertens. 2016;25(6):545–50.CrossRefPubMed Gul A, Miskulin D, Harford A, Zager P. Intradialytic hypotension. Curr Opin Nephrol Hypertens. 2016;25(6):545–50.CrossRefPubMed
16.
17.
go back to reference KD W. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:1–S153. KD W. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:1–S153.
18.
go back to reference de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20(9):2075–84.CrossRefPubMedPubMedCentral de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20(9):2075–84.CrossRefPubMedPubMedCentral
19.
go back to reference Lohman T, Roche AF, Martorell R. Anthropometric standardization reference manual. ed. Champaign IL: Human Kinetics Books; 1988. Lohman T, Roche AF, Martorell R. Anthropometric standardization reference manual. ed. Champaign IL: Human Kinetics Books; 1988.
20.
go back to reference Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38(6):1251–63.CrossRefPubMed Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38(6):1251–63.CrossRefPubMed
21.
go back to reference Cohen J. Statistical power analysis for the behavioural sciences. Volume 56. Hillsdale, New Jersey: L. Lea; 1988. p. 102. Cohen J. Statistical power analysis for the behavioural sciences. Volume 56. Hillsdale, New Jersey: L. Lea; 1988. p. 102.
22.
go back to reference Kalantar-Zadeh K, Block G, Kelly MP, Schroepfer C, Rodriguez RA, Humphreys MH. Near Infra-Red Interactance for Longitudinal Assessment of Nutrition in Dialysis Patients. J Ren Nutr. 2001;11(1):23–31.CrossRefPubMed Kalantar-Zadeh K, Block G, Kelly MP, Schroepfer C, Rodriguez RA, Humphreys MH. Near Infra-Red Interactance for Longitudinal Assessment of Nutrition in Dialysis Patients. J Ren Nutr. 2001;11(1):23–31.CrossRefPubMed
23.
go back to reference Beberashvili I, Azar A, Sinuani I, Kadoshi H, Shapiro G, Feldman L, Averbukh Z, Weissgarten J. Comparison analysis of nutritional scores for serial monitoring of nutritional status in hemodialysis patients. Clin J Am Soc Nephrology: CJASN. 2013;8(3):443.CrossRef Beberashvili I, Azar A, Sinuani I, Kadoshi H, Shapiro G, Feldman L, Averbukh Z, Weissgarten J. Comparison analysis of nutritional scores for serial monitoring of nutritional status in hemodialysis patients. Clin J Am Soc Nephrology: CJASN. 2013;8(3):443.CrossRef
24.
go back to reference Cheng THT, Lam DHH, Ting SKL, Wong CLY, Kwan BCH, Chow KM, Law MC, Li PKT, Szeto CC. Serial monitoring of nutritional status in chinese peritoneal dialysis patients by Subjective Global Assessment and comprehensive malnutrition inflammation score. Nephrology. 2009;14(2):143–7.CrossRefPubMed Cheng THT, Lam DHH, Ting SKL, Wong CLY, Kwan BCH, Chow KM, Law MC, Li PKT, Szeto CC. Serial monitoring of nutritional status in chinese peritoneal dialysis patients by Subjective Global Assessment and comprehensive malnutrition inflammation score. Nephrology. 2009;14(2):143–7.CrossRefPubMed
25.
go back to reference Blumenkrantz M, Ings TS. In.: Boston, Little, Brown and Company; 1994. Blumenkrantz M, Ings TS. In.: Boston, Little, Brown and Company; 1994.
26.
go back to reference Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int. 1999;55(5):1945–51.CrossRefPubMed Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int. 1999;55(5):1945–51.CrossRefPubMed
27.
go back to reference Owen WF. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998;54(2):627–36.CrossRefPubMed Owen WF. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998;54(2):627–36.CrossRefPubMed
28.
go back to reference Cooper BA, Penne EL, Bartlett LH, Pollock CA. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis. 2004;43(1):61–6.CrossRefPubMed Cooper BA, Penne EL, Bartlett LH, Pollock CA. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis. 2004;43(1):61–6.CrossRefPubMed
29.
go back to reference Luster AD. Chemokines — chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338(7):436–45.CrossRefPubMed Luster AD. Chemokines — chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338(7):436–45.CrossRefPubMed
30.
go back to reference Jacobs A, Miller F, Worwood M, Beamish MR, Wardrop CA. Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J. 1972;4(5834):206–8.CrossRefPubMedPubMedCentral Jacobs A, Miller F, Worwood M, Beamish MR, Wardrop CA. Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J. 1972;4(5834):206–8.CrossRefPubMedPubMedCentral
31.
go back to reference Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of Iron Stores. N Engl J Med. 1974;290(22):1213–6.CrossRefPubMed Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of Iron Stores. N Engl J Med. 1974;290(22):1213–6.CrossRefPubMed
32.
go back to reference Kliger AS, Foley RN, Goldfarb DS, Goldstein SL, Johansen K, Singh A, Szczech L. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis. 2013;62(5):849–59.CrossRefPubMed Kliger AS, Foley RN, Goldfarb DS, Goldstein SL, Johansen K, Singh A, Szczech L. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis. 2013;62(5):849–59.CrossRefPubMed
33.
go back to reference Pecoits-Filho R, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis. 2003;41(6):1212–8.CrossRefPubMed Pecoits-Filho R, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B, Stenvinkel P. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis. 2003;41(6):1212–8.CrossRefPubMed
34.
go back to reference Cho N-J, Jeong S-H, Lee KY, Yu JY, Park S, Lee EY, Gil H-W. Clinical safety of expanded hemodialysis compared with Hemodialysis using high-flux dialyzer during a three-year cohort. J Clin Med. 2022;11(8):2261.CrossRefPubMedPubMedCentral Cho N-J, Jeong S-H, Lee KY, Yu JY, Park S, Lee EY, Gil H-W. Clinical safety of expanded hemodialysis compared with Hemodialysis using high-flux dialyzer during a three-year cohort. J Clin Med. 2022;11(8):2261.CrossRefPubMedPubMedCentral
35.
go back to reference Fung WW-S, Poon PY-K, Ng JK-C, Kwong VW-K, Pang W-F, Kwan BC-H, Cheng PM-S, Li PK-T, Szeto C-C. Longitudinal changes of NF-κB downstream mediators and peritoneal transport characteristics in incident peritoneal dialysis patients. Sci Rep. 2020;10(1):6440.CrossRefPubMedPubMedCentral Fung WW-S, Poon PY-K, Ng JK-C, Kwong VW-K, Pang W-F, Kwan BC-H, Cheng PM-S, Li PK-T, Szeto C-C. Longitudinal changes of NF-κB downstream mediators and peritoneal transport characteristics in incident peritoneal dialysis patients. Sci Rep. 2020;10(1):6440.CrossRefPubMedPubMedCentral
36.
go back to reference Maggiore Q. Effect of extracoporeal blood cooling on dialytic arterial hypotension. In: Proc EDTA: 1981; 1981: 597–602. Maggiore Q. Effect of extracoporeal blood cooling on dialytic arterial hypotension. In: Proc EDTA: 1981; 1981: 597–602.
37.
go back to reference Mustafa RA, Bdair F, Akl EA, Garg AX, Thiessen-Philbrook H, Salameh H, Kisra S, Nesrallah G, Al-Jaishi A, Patel P, et al. Effect of lowering the Dialysate temperature in chronic hemodialysis: a systematic review and Meta-analysis. Clin J Am Soc Nephrol. 2016;11(3):442–57.CrossRefPubMed Mustafa RA, Bdair F, Akl EA, Garg AX, Thiessen-Philbrook H, Salameh H, Kisra S, Nesrallah G, Al-Jaishi A, Patel P, et al. Effect of lowering the Dialysate temperature in chronic hemodialysis: a systematic review and Meta-analysis. Clin J Am Soc Nephrol. 2016;11(3):442–57.CrossRefPubMed
38.
go back to reference Ahmadi F, Toulabi T, Ebrahimzadeh F, Sajadi M. The effects of cool dialysate on vital signs, adequacy and complications during hemodialysis. Iran J Nurs Midwifery Res 2021. Ahmadi F, Toulabi T, Ebrahimzadeh F, Sajadi M. The effects of cool dialysate on vital signs, adequacy and complications during hemodialysis. Iran J Nurs Midwifery Res 2021.
39.
go back to reference Ayoub A, Finlayson M. Effect of cool temperature dialysate on the quality and patients’ perception of haemodialysis. Nephrol Dialysis Transplantation. 2004;19(1):190–4.CrossRef Ayoub A, Finlayson M. Effect of cool temperature dialysate on the quality and patients’ perception of haemodialysis. Nephrol Dialysis Transplantation. 2004;19(1):190–4.CrossRef
40.
go back to reference Jefferies HJ, Burton JO, McIntyre CW. Individualised Dialysate temperature improves intradialytic haemodynamics and abrogates Haemodialysis-Induced Myocardial Stunning, without compromising tolerability. Blood Purif. 2011;32(1):63–8.CrossRefPubMed Jefferies HJ, Burton JO, McIntyre CW. Individualised Dialysate temperature improves intradialytic haemodynamics and abrogates Haemodialysis-Induced Myocardial Stunning, without compromising tolerability. Blood Purif. 2011;32(1):63–8.CrossRefPubMed
41.
go back to reference Ebrahimi H, Safavi M, Saeidi MH, Emamian MH. Effects of Sodium concentration and dialysate temperature changes on blood pressure in hemodialysis patients: a randomized, triple-blind crossover clinical trial. Therapeutic Apheresis and Dialysis. 2017;21(2):117–25.CrossRefPubMed Ebrahimi H, Safavi M, Saeidi MH, Emamian MH. Effects of Sodium concentration and dialysate temperature changes on blood pressure in hemodialysis patients: a randomized, triple-blind crossover clinical trial. Therapeutic Apheresis and Dialysis. 2017;21(2):117–25.CrossRefPubMed
42.
go back to reference Tsujimoto Y, Tsujimoto H, Nakata Y, Kataoka Y, Kimachi M, Shimizu S, Ikenoue T, Fukuma S, Yamamoto Y, Fukuhara S. Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis. Cochrane Database Syst Rev. 2019;7(7):CD012598–8.PubMed Tsujimoto Y, Tsujimoto H, Nakata Y, Kataoka Y, Kimachi M, Shimizu S, Ikenoue T, Fukuma S, Yamamoto Y, Fukuhara S. Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis. Cochrane Database Syst Rev. 2019;7(7):CD012598–8.PubMed
Metadata
Title
Could cooling dialysate improve inflammatory and nutritional status of hemodialysis patients?
Authors
Asmaa Elemshaty
Nagy Sayed-Ahmed
Abeer Mesbah
Mohammed Kamal Nassar
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03305-z

Other articles of this Issue 1/2023

BMC Nephrology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine